SLAS discovery : advancing life sciences R & DHumansB7-H1 AntigenHead and Neck NeoplasmsFluorescent Antibody TechniqueCell Line
High-content immunofluorescence assay detecting PD-L1 expression changes in head and neck cancer patient-derived cultures.
Yuen-Keng Ng, Stacy Magdalene Abbang, Jishi Ye, Wenying Piao, Yu-Xiong Su, Jason Ying Kuen Chan, Chin Wang Lau, Cecilia Pik Yuk Lau, Hui Li, Vivian Wai Yan Lui
Published: 202510.1016/j.slasd.2025.100286
Abstract
Clinical uses of monoclonal antibodies against immune checkpoint molecules, such as the Program Death-Ligand 1 (PD-L1) or Program Death Protein-1 (PD-1), has transformed cancer therapy across pan-cancers. In addition to antibody therapies, there is a…
Preview only. Read the full abstract at the source